Off-Label Use

Promising Alzheimer's drug fails in follow-up tests, researchers announce

By

A "breakthrough" Alzheimer's drug now looks much less promising after follow-up experiments failed to reproduce successful results, scientists recently announced. Non-standard use of the drug should be halted, they say.

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

By

Long-term care pharmacy Omnicare will not face charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces more limited False Claims Act charges over billing for antipsychotic drugs allegedly used for dementia care.

Proposed legislation would regulate use of antipsychotics in nursing home residents

Proposed legislation would regulate use of antipsychotics in nursing home residents

By

A proposed bill would require nursing home staff to obtain informed consent from a resident or their legally designated representative acknowledging the potential risks and side effects associated with the antipsychotic medications.

Antipsychotic likely to increase mortality risk in dementia residents, study finds

By

Nursing home residents being treated for dementia with the antipsychotic drug haloperidol were at a two-fold risk of mortality compared to other antipsychotics, a new study finds.